S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling

Journal of Neurochemistry

Volumn 117, Issue 2, 2011, Pages 321-332

  Villarreal, Alejandro ^a   Aviles Reyes, Rolando X ^a   Angelo, Maria Florencia ^a   Reinesf, Analia G ^b   Ramos, Alberto Javier ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Instituto de Investigaciones Farmacologicas   (Argentina)

Author keywords

Apoptosis; Glia; Ischemia; Neuronal death

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN S100B; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; BRAIN CELL; BRAIN ISCHEMIA; CELL DEATH; CELL SHAPE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY TEST; DENDRITE; EXCITOTOXICITY; MALE; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; ANTIBODIES; BRAIN ISCHEMIA; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DENDRITES; DRUG INTERACTIONS; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GLUTAMIC ACID; MALE; NEURONS; NF-KAPPA B; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS; SIGNAL TRANSDUCTION; SULFADIAZINE; TIME FACTORS;

EID: 79953693557     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07207.x     Document Type: Article

References (63)

1. Ahlemeyer B., Holger B., Irina S., Christine S. and Josef K. (2000) S-100B protects neurons against glutamate- and staurosporineinduced damage and is involved in the antiaptotic action of the 5HT1A- receptor agonist, Bay x 3702. Brain Res. 858, 121-128.
2. Alexanian A. R. and Bamburg J. R. (1999) Neuronal survival activity of s100beta is enhanced by calcineurin inhibitors and requires activation of NF-kappaB. FASEB J. 13, 1611-1620. (Pubitemid 29411795)
3. Angelo M. F., Aviles-Reyes R. X., Villarreal A., Barker P., Reines A. G. and Ramos A. J. (2009) p75(NTR) Expression is induced in isolated neurons of the penumbra after ischemia by cortical devascularization. J. Neurosci. Res. 87, 1892-1903.
4. Asano T., Mori T., Shimoda T., Shinagawa R., Satoh S., Yada N., Katsumata S., Matsuda S., Kagamiishi Y. and Tateishi N. (2005) Arundic acid (ONO-2505) amiliorates delayed ischemic brain damage by preventing astrocytic overproduccion of S100B. Curr. Drug Targets CNS Neurol. Disord. 4, 127-142.
5. Aviles-Reyes R. X., Angelo M. F., Villarreal A., Rios H., Lazarowski A. and Ramos A. J. (2010) Intermittent hypoxia during sleep induces reactive gliosis and limited neuronal death in rats: implications for sleep apnea. J. Neurochem. 112, 854-869.
6. Azmitia E. C. and Whitaker-Azmitia P. M. (1991) Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic System. J. Clin. Psychiatry 52, 4-16.
7. Bhakar A. L., Tannis L. L., Zeindler C., Russo M. P., Jobin C., Park D. S., MacPherson S. and Barker P. A. (2002) Constitutive nuclear factor-kappa B activity is required for central neuron survival. J. Neurosci. 22, 8466-8475. (Pubitemid 35387587)
8. Braga C. W., Martinez D., Wofchuk S., Portela L. V. and Souza D. O. (2006) S100B and NSE serum levels in obstructive sleep apnea syndrome. Sleep Med. 7, 431-435. (Pubitemid 44103489)
9. Brewton L. S., Haddad L. and Azmitia E. C. (2001) Colchicine-induced cytoskeletal collapse and apoptosis in N-18 neuroblastoma cultures is rapidly reversed by applied S-100beta. Brain Res. 912, 9-16. (Pubitemid 32772787)
10. Businaro R., Leone S., Fabrizi C., Sorci G., Donato R., Lauro G. M. and Fumagalli L. (2006) S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses. J. Neurosci. Res. 83, 897-906.
11. Chen L. F. and Greene W. C. (2004) Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 5, 392-401.
12. Chou D. K., Zhang J., Smith F. I., McCaffery P. and Jungalwala F. B. (2004) Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration. J. Neurochem. 90, 1389-1401. (Pubitemid 39223642)
13. 2+ levels regulate the alternative cell density-dependent secretion of S100B in human glioblastoma cells. J. Biol. Chem. 276, 30819-30826.
14. Donato R. (2003) Intracellular and extracellular roles of S100 proteins. Microsci. Res. Tech. 60, 540-551.
15. Donato R. (2007) RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr. Mol. Med. 7, 711-724.
16. Donato R., Sorci G., Riuzzi F., Arcuri C., Bianchi R., Brozzi F., Tubaro C. and Giambanco I. (2009) S100B's double life: intracellular regulator and extracellular signal. Biochim. Biophys. Acta 1793, 1008-1022.
17. Figueiredo B. C., Piccardo P., Maysinger D., Clarke P. B. and Cuello A. C. (1993) Effects of acidic fibroblast growth factor on cholinergic neurons of nucleus basalis magnocellularis and in a spatial memory task following cortical devascularization. Neuroscience 56, 955-963. (Pubitemid 23308650)
18. Fiuza C., Bustin M., Talwar S., Tropea M., Gerstenberger E., Shelhamer J. H. and Suffredini A. F. (2003) Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101, 2652-2660. (Pubitemid 36857626)
19. Gerlach R., Demel G., König H.-G., Gross U., Prehn J. H. M., Raabe A., Seifert V. and Kögel D. (2006) Active secretion of S100B from astrocytes during metabolic stress. Neuroscience 141, 1697-1701. (Pubitemid 44233123)
20. Goslin K., Schreyer D. J., Skene J. H. and Banker G. (1988) Development of neuronal polarity: GAP-43 distinguishes axonal from dendritic growth cones. Nature 336, 672-674. (Pubitemid 19007946)
21. Hassid B. G., Nair M. N., Ducruet A. F., Otten M. L., Komotar R. J., Pinsky D. J., Schmidt A. M., Yan S. F. and Connolly E. S. (2009) Neuronal RAGE expression modulates severity of injury following transient focal cerebral ischemia. J. Clin. Neurosci. 16, 302-306.
22. Herrera D. G. and Robertson H. A. (1989) Unilateral induction of c-fos protein in cortex following cortical devascularization. Brain Res. 503, 205-213.
23. Ho W. C., Dickson K. M. and Barker P. A. (2005) Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB dependent transcription in cancer cells. Cancer Res. 65, 4273-4281. (Pubitemid 40775666)
24. Hofmann M. A., Drury S., Fu C. et al. (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97, 889-901. (Pubitemid 29375048)
25. Hu J., Ferreira A. and Van Eldik L. J. (1997) S100beta induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69, 2294-2301. (Pubitemid 27495414)
26. Huttunen H. J., Fages C. and Rauvala H. (1999) Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274, 19919-19924.
27. Huttunen H. J., Kuja-Panula J., Sorci G., Agneletti A. L., Donato R. and Rauvala H. (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 275, 40096-40105.
28. Kim J. B., Lim C. M., Yu Y. M. and Lee J. K. (2008) Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain. J. Neurosci. Res. 86, 1125-1131.
29. Kligman D. and Hilt D. C. (1988) The S100 protein family. Trends Biochem. Sci. 13, 437-443.
30. Kligman D. and Marshak D. R. (1985) Purification and characterization of a neurite extension factor from bovine brain. Proc. Natl. Acad. Sci. U S A 82, 7136-7139.
31. Kögel D., Peters M., König H. G., Hashemi S. M., Bui N. T., Arolt V., Rothermundt M. and Prehn J. H. (2004) S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons. Clinical implicances for the role of S100B in excitotoxic brain injury. Neuroscience 127, 913-920.
32. Kommaddi R. P., Dickson K. M. and Barker P. A. (2011) Stress-induced expression of the p75 neurotrophin receptor is regulated by O-GlcNAcylation of the Sp1 transcription factor. J. Neurochem. 116, 396-405.
33. Li J. and Schmidt A. M. (1997) Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J. Biol. Chem. 272, 16498-16506.
34. Li J., Qu X. and Schmidt A. M. (1998) Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells. J. Biol. Chem. 273, 30870-30878.
35. Liu K., Mori S., Takahashi H. K. et al. (2007) Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J. 21, 3904-3916. (Pubitemid 350232348)
36. Ma L., Carter R. J., Morton A. J. and Nicholson L. F. (2003) RAGE is expressed in pyramidal cells of the hippocampus following moderate hypoxic-ischemic brain injury in rats. Brain Res. 966, 167-174. (Pubitemid 36255580)
37. Manev R., Uz T. and Manev H. (2001) Fluoxetine increases the content of neurotrophic protein S100beta in the rat hippocampus. Eur. J. Pharmacol. 420, R1-2.
38. Matsui T., Mori T., Tateishi N., Kagamiishi N., Satoh S., Katsube N., Morikawa E., Morimoto T., Ikuta F. and Asano T. (2002) Astrocytic activation and delayed infartct expansion after permanent focal ischemia in rats. Part I: enhanced astrocytic synthesis of S100B in the periinfarct area precedes delayed infarct expansion. J. Cereb. Flow Metab. 22, 711-722.
39. Meijering E., Jacob M., Sarria J., Steiner P., Hirling H. and Unser M. (2004) Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry Part A 58, 167-176. (Pubitemid 38509178)
40. Muhammad S., Barakat W., Stoyanov S. et al. (2008) The HMGB1 receptor RAGE mediates ischemic brain damage. J. Neurosci. 28, 12023-12031.
41. Nishi M., Kawata M. and Azmitia E. C. (1997) S100beta promotes the extension of microtubule associated protein2 (MAP2)-immunoreactive neurites retracted after colchicines treatment in rat spinal cord culture. Neurosci. Lett. 229, 212-214.
42. Nishi M., Kawata M. and Azmitia E. C. (2000) Trophic interactions between brain-derived neurotrophic factor and s100beta on cultured serotonergic neurons. Brain Res. 868, 113-118. (Pubitemid 30332349)
43. Nishiyama H., Knopfel T., Endo S. and Itohara S. (2002) Glial protein S100B modulates long-term neuronal synaptic plasticity. Proc. Natl. Acad. Sci. U S A 99, 4037-4042.
44. Perkins N. D. (2006) Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25, 6717-6730.
45. Pichiule P., Chavez J. C., Schmidt A. M. and Vannucci S. J. (2007) Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia. J. Biol. Chem. 282, 36330-36340.
46. Qiu J., Nishimura M., Wang Y., Sims J. R., Qiu S., Savitz S. I., Salomone S. and Moskowitz M. A. (2008) Early release of HMGB-1 from neurons after the onset of brain ischemia. J. Cereb. Blood Flow Metab. 28, 927-938.
47. Ramasamy R., Yan S. F. and Schmidt A. M. (2009) RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts. J. Leukoc. Biol. 86, 505-512.
48. Ramos A. J., Rubio M. D., Defagot C., Hischberg L., Villar M. J. and Brusco A. (2004) The 5HT1a receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization. Brain Res. 1030, 201-220. (Pubitemid 39574953)
49. Ramos A., Ho W. C., Forte S., Dickson K., Boutilier J., Favell K. and Barker P. A. (2007) Hyposmolarity induces p75ntr expression in central nervous system neurons by activating sp1-dependent transcription. J. Neurosci. 27, 1498-1506.
50. Reeves R. H., Yao J., Crowley M. R., Buck S., Zhang X., Yarowsky P., Gearhart J. D. and Hilt D. C. (1994) Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice. Proc. Natl. Acad. Sci. U S A 91, 5359-5363.
51. Ridder D. A. and Schwaninger M. (2009) NF-kappaB signaling in cerebral ischemia. Neuroscience 158, 995-1006.
52. Rong L. L., Gooch C. and Szaboles M. (2005) RAGE: a journey from the complications of diabetes to disorders of the nervous system striking a fine balance between injury and repair. Restor. Neurol. Neurosci. 23, 355-365.
53. Rothermundt M., Peters M., Prehn J. H. and Arolt V. (2003) S100B in brain damage and neurodegeneration. Microsci. Res. Tech. 60, 614-632.
54. Sorci G., Agneletti A. L. and Donato R. (2000) Effects of S100A1 and S100B on microtubule stability. An in vitro study using tritoncytoskeletons from astrocyte and myoblast cell lines. Neuroscience 99, 773-783.
55. Tanaka N., Yonekura H., Yamagishi S., Fujimori H., Yamamoto Y. and Yamamoto H. (2000) The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J. Biol. Chem. 275, 25781-25790.
56. Tramontina A. C., Tramontina F., Bobermin L. D., Zanotto C., Souza D. F., Leite M. C., Nardin P., Gottfried C. and Gonçalves C. A. (2008) Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1580-1583.
57. Van Eldik L. J. and Griffin W. S. (1994) S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim. Biophys. Acta 1223, 398-403.
58. Vincent A. M., Perrone L., Sullivan K. A., Backus C., Sastry A. M., Lastoskie C. and Feldman E. L. (2007) Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 148, 548-558. (Pubitemid 46143159)
59. Wang L., Li S. and Jungalwala F. B. (2008) Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth. J. Neurosci. Res. 86, 1254-1266.
60. Xiong Z., O'Hanlon D., Becker L. E., Roder J., MacDonald J. F. and Marks A. (2000) Enhanced calcium transients in glial cells in neonatal cerebellar cultures derived from S100B null mice. Exp. Cell Res. 257, 281-289.
61. Zhai D. X., Kong Q. F., Xu W. S. et al. (2008) RAGE expression is upregulated in human cerebral ischemia and pMCAO rats. Neurosci. Lett. 445, 117-121.
62. Zhang W., Potrovita I., Tarabin V., Herrmann O., Beer V., Weih F., Schneider A. and Schwaninger M. (2005) Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 25, 30-40.
63. Zhou F. C., Azmitia E. C. and Bledsoe S. (1995) Rapid serotonergic fiber sprouting in response to ibotenic acid lesion in the striatum and hippocampus. Dev. Brain Res. 84, 89-98.